SIGN IN YOUR ACCOUNT TO HAVE ACCESS TO DIFFERENT FEATURES

FORGOT YOUR PASSWORD?

FORGOT YOUR DETAILS?

AAH, WAIT, I REMEMBER NOW!
+1 786 238 2170

Global Stem Cells GroupGlobal Stem Cells Group

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Press Releases
  • Blog
CONTACT
  • Home
  • Corporate News / Blog
  • Blood plasma reduces symptoms and fatalities in outbreaks of coronavirus.
June 12, 2025

Blood plasma reduces symptoms and fatalities in outbreaks of coronavirus.

Monday, April 13, 2020 / Published in Corporate News / Blog

Blood plasma reduces symptoms and fatalities in outbreaks of coronavirus.

Blood Plasma Reduces Symptoms and Fatalities in Outbreaks of Coronavirus

US blood donation centers are actively collecting plasma from COVID-19 survivors to treat current patients infected with the disease. Convalescent plasma therapy, an old treatment method revived for COVID-19, involves using blood products from recovered patients to inject into those still battling the virus. This approach, historically used as far back as the 1930s for diseases like measles and more recently for H1N1 influenza, SARS, and Ebola, has shown promise in reducing symptoms and fatalities during past coronavirus outbreaks.

History and Effectiveness of Convalescent Plasma Therapy

Clinical research has demonstrated that convalescent plasma can provide hope in treating COVID-19 patients by temporarily boosting their immune response until they develop their own antibodies. This therapy has gained attention due to its potential to mitigate severe symptoms in the absence of specific treatments or vaccines.

Current Efforts and Clinical Trials

Following FDA authorization for emergency use, centers like Houston Methodist Hospital have started administering convalescent plasma to critically ill COVID-19 patients. Ongoing clinical trials across various locations, including the New York Blood Center and American Red Cross, aim to validate the effectiveness of plasma therapy in combating the pandemic.

Guidelines and Collection Process

According to AABB guidelines, plasma is collected from donors who have recovered from COVID-19, tested negative, and been symptom-free for at least 28 days. Efforts are underway to streamline antibody testing for donors and quickly administer plasma to critically ill patients to maximize its therapeutic potential.

Future Prospects and Collaborative Efforts

Collaborations between AABB, America’s Blood Centers, and medical institutions are expected to expand plasma therapy practices exponentially, facilitating broader access and implementation. Emergency IND authorization from the FDA allows for the immediate distribution of collected plasma to patients, marking a significant step in pandemic response efforts.

Personal Stories and Community Engagement

Individuals like Dr. Jon Peters, a family practice physician recovering from COVID-19, are eager to contribute by donating plasma once they meet recovery criteria. Such donations are critical in providing a low-risk, potentially lifesaving treatment option for those affected by the pandemic.

To learn more about convalescent plasma therapy for COVID-19 and participate in ongoing research efforts, visit www.issca.us and stay updated on the latest developments in combating the coronavirus pandemic.

Tagged under: Convalescent plasma therapy, COVID-19, disastrous flu, ebola, H1N1, plasma therapy, SARS, viral disease

What you can read next

The different types of stem cells and their current uses
PROTEINS PRODUCED BY STEM CELLS, USED IN BONE REGENERATION
STANFORD RESEARCHERS ISOLATE SKELETAL STEM CELLS THAT GIVE RISE TO BONES AND CARTILAGE

Leave a Reply

Your email address will not be published. Required fields are marked *

Send Us a Message

Contact Home GSCG website

Name(Required)
Email(Required)
Please let us know what's on your mind. Have a question for us? Ask away.
  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

  • Home
  • Our Story
  • Speakers
  • Investors
  • Companies
  • Testimonials
  • Press Releases
  • Blog

Copyright © 2024 Stem Cells Group | All Rights Reserved

CONTACT US

Datran Center 9100 S Dadeland Boulevard, Suite 1500. Miami Fl. 33156 United States

305-560-5337

info@stemcellsgroup.com

STAY CONNECTED

Get the latest news, updates, and promotions. Follow us on our social networks.

Certification issued by ISSCA

TOP